实例探究 > Leading drugstore chain chooses LexisNexis®

Leading drugstore chain chooses LexisNexis®

公司规模
1,000+
地区
  • America
国家
  • United States
产品
  • VerifyRx™
  • LexisNexis® Heath Care
技术栈
  • Big Data Technology Platform
实施规模
  • Enterprise-wide Deployment
影响指标
  • Cost Savings
  • Customer Satisfaction
  • Productivity Improvements
技术
  • 分析与建模 - 大数据分析
  • 网络安全和隐私 - 安全合规
  • 功能应用 - 企业资源规划系统 (ERP)
适用行业
  • 医疗保健和医院
  • 零售
适用功能
  • 商业运营
  • 质量保证
用例
  • 欺诈识别
  • 监管合规监控
  • 远程资产管理
服务
  • 数据科学服务
  • 系统集成
关于客户
The customer is a major U.S. pharmacy chain that operates on a large scale, filling more than 5 billion retail prescription drugs at U.S. pharmacies in 2016. The pharmacy chain faces significant challenges in discerning the validity of prescriptions due to ongoing prescriber regulatory challenges, varying payer requirements, licensure inconsistencies, intricate drug diversion schemes, and stringent claims audits by the Centers for Medicare & Medicaid Services. These challenges make validating every prescription an operational risk, with potential consequences ranging from inappropriate reimbursement to tens of millions of dollars in fines for record-keeping, dispensing, and narcotics violations. The pharmacy chain requires a reliable solution that incorporates current information about prescribers and enables alignment with all relevant regulations to verify prescriber information prior to billing and dispensation. The pharmacy chain is also dealing with systems that were not designed for the complexity of today’s prescription claims process, resulting in a workflow that is not conducive to supporting pharmacists’ primary roles of patient service and safety.
挑战
Discerning the validity of prescriptions today is a complicated process made more complex by a number of factors, including ongoing prescriber regulatory challenges impacting daily pharmacy operations, varying payer requirements causing discrepancies, licensure inconsistencies across prescribers, intricate drug diversion schemes, and more stringent claims audits by the Centers for Medicare & Medicaid Services. Together, these issues make validating every prescription an operational challenge and risk, with consequences ranging from inappropriate reimbursement to tens of millions of dollars in fines for record-keeping, dispensing, and narcotics violations. The Drug Enforcement Administration (DEA) using their own federal data and data from state-level licensing boards to determine prescriptive authority is causing an even more complicated regulatory environment for retailers. Add to this the increased scrutiny from the media and others, and it is clear that retail pharmacies need a reliable solution—one that incorporates current information about prescribers and enables alignment with all relevant regulations in order to verify prescriber information prior to billing and dispensation. Unfortunately, many pharmacies are working with systems that were not designed for the complexity of today’s prescription claims process, often ingesting and matching data and technology components that are not designed to work together efficiently. The result is a workflow that is far from conducive to supporting pharmacists’ primary roles—patient service and safety.
解决方案
To address this critical need, the major U.S. pharmacy chain chose VerifyRx™ from LexisNexis® Heath Care. In the retail setting, VerifyRx performs real-time prescriber verification checks before adjudication, reducing the risk of regulatory penalties due to preventable mistakes and overall compliance risk, and increasing the percentage of paid prescription claims. Through alignment with specific requirements and all relevant state and federal regulations, the solution also reduces time to dispense and helps prevent mistakes that could cause payments to be taken back or expose pharmacies and PBMs to further regulatory risk. Leveraging a powerful big data technology platform, VerifyRx processes millions of transactions a day with response times measured in milliseconds, enabling swift and effective identification of potential submission errors. Since the prescriber data is used by both leading retail pharmacies and leading PBMs, this correlation of information further reduces discrepancies that can stall efficiency. Among its other features and benefits, VerifyRx provides access to the timeliest data available, including real-time updates from the DEA and state data (when available), as compared to waiting for standard higher-latency delivery of batch files. It also offers instant audit defense, creating an audit trail through real-time logging, traceability to state and federal source data for each transaction, and monitoring and reporting of compliance performance. The solution is highly configurable to meet compliance, legal, and business needs with current data on state and federal prescriptive authority at the taxonomy and credential level. This includes federal and state sanctions data, DEA and state license status, grace-period allowance, and the ability to reject, warn, or capture responses by check. VerifyRx also includes over 60 checks, resulting from 7 years of feedback from users working to meet industry compliance challenges.
运营影响
  • A review of prescriptions presented to the large retail pharmacy chain in 2016 showed the system had prevented nearly 11.7 million irregularities uncovered in various categories, including DEA issues, NPI issues, sanctions, exclusions, deceased prescribers, XDEA issues, and state license issues.
  • Beyond the numbers, the chain’s pharmacists were able to meet their dispensing responsibilities with greater efficiency and less stress, allowing them to focus on the patient’s needs.
  • The company itself was better fortified against litigation and audits, and improved reimbursement rates bolstered the bottom line.
  • VerifyRx allows corporate compliance to focus on compliance challenges, rather than on IT efforts and scheduling.
  • The organization also reduced its compliance risk with automatic updates of changing laws and regulations, thereby playing a significant role in preventing fraud and abuse associated with prescription drugs.
数量效益
  • DEA issues, including prescriptive authority: 1,180,999
  • NPI issues: 358,883
  • Sanction, exclusions: 663,326
  • Deceased: 26,279
  • XDEA issues: 483,211

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

相关案例.

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。